| Dr Thomas John Kaminsky, MD | |
|
15700 37th Ave N Ste 300, Plymouth, MN 55446-3661 | |
| (612) 871-1145 | |
| (612) 870-5491 |
| Full Name | Dr Thomas John Kaminsky |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 10 Years |
| Location | 15700 37th Ave N Ste 300, Plymouth, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033524608 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 125065759 (Illinois) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 68994 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Memorial Health | Robbinsdale, MN | Hospital |
| Maple Grove Hospital | Maple grove, MN | Hospital |
| Mercy Hospital | Coon rapids, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mngi Digestive Health Pa | 8123016557 | 247 |
News Archive
CEVEC Pharmaceuticals, the developer of an extremely potent protein expression system based on human CAP cells, announced today that CAP cells produce high virus titers upon infection with influenza strains. The virus titers are as good as or even higher than with MDCK and Vero cells, host cells currently used for influenza vaccine production.
Actavis plc today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.
IntegraMed America, Inc., a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that it has entered into a definitive agreement to be acquired by affiliates formed by Sagard Capital Partners, L.P., an investment fund and IntegraMed shareholder, for $14.05 per share in cash, or a total equity purchase price of $169.5 million.
A history of diabetes and elevated levels of cholesterol, especially LDL cholesterol, are associated with faster cognitive decline in patients with Alzheimer's disease, according to a new study from Columbia University Medical Center researchers.
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has expanded its leading medical imaging capabilities with advanced nuclear imaging functionality for cardiology clinical trials.
› Verified 1 days ago
| Entity Name | Mngi Digestive Health Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609804541 PECOS PAC ID: 8123016557 Enrollment ID: O20040504001467 |
News Archive
CEVEC Pharmaceuticals, the developer of an extremely potent protein expression system based on human CAP cells, announced today that CAP cells produce high virus titers upon infection with influenza strains. The virus titers are as good as or even higher than with MDCK and Vero cells, host cells currently used for influenza vaccine production.
Actavis plc today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.
IntegraMed America, Inc., a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that it has entered into a definitive agreement to be acquired by affiliates formed by Sagard Capital Partners, L.P., an investment fund and IntegraMed shareholder, for $14.05 per share in cash, or a total equity purchase price of $169.5 million.
A history of diabetes and elevated levels of cholesterol, especially LDL cholesterol, are associated with faster cognitive decline in patients with Alzheimer's disease, according to a new study from Columbia University Medical Center researchers.
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has expanded its leading medical imaging capabilities with advanced nuclear imaging functionality for cardiology clinical trials.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas John Kaminsky, MD Po Box 14909, Minneapolis, MN 55414-0909 Ph: (612) 871-1145 | Dr Thomas John Kaminsky, MD 15700 37th Ave N Ste 300, Plymouth, MN 55446-3661 Ph: (612) 871-1145 |
News Archive
CEVEC Pharmaceuticals, the developer of an extremely potent protein expression system based on human CAP cells, announced today that CAP cells produce high virus titers upon infection with influenza strains. The virus titers are as good as or even higher than with MDCK and Vero cells, host cells currently used for influenza vaccine production.
Actavis plc today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.
IntegraMed America, Inc., a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that it has entered into a definitive agreement to be acquired by affiliates formed by Sagard Capital Partners, L.P., an investment fund and IntegraMed shareholder, for $14.05 per share in cash, or a total equity purchase price of $169.5 million.
A history of diabetes and elevated levels of cholesterol, especially LDL cholesterol, are associated with faster cognitive decline in patients with Alzheimer's disease, according to a new study from Columbia University Medical Center researchers.
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has expanded its leading medical imaging capabilities with advanced nuclear imaging functionality for cardiology clinical trials.
› Verified 1 days ago
Erica N. Roberson, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N, #300, Plymouth, MN 55446 Phone: 612-871-1145 Fax: 612-870-5491 | |
Alfred P. Chiang, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2700 Campus Dr, Suite 100, Plymouth, MN 55441 Phone: 763-519-0634 Fax: 763-519-0636 | |
Mr. Bradley Daniel Chmielewski, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2800 Campus Dr Ste 10, Plymouth, MN 55441 Phone: 763-559-2171 | |
Daniela T Ouzounova, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2855 Campus Dr, Ste. 400, Plymouth, MN 55441 Phone: 763-577-7400 | |
Stephanie Norris, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3007 Harbor Ln N, Plymouth, MN 55447 Phone: 952-993-8900 | |
Dr. Daniel Mark Van Handel, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 300, Plymouth, MN 55446 Phone: 612-871-1145 Fax: 612-870-5491 |